Contact Us
Drug Search Results
More Filters [+]

OCV-C02

Alternative Names: ocv-c02, ocv c02, ocvc02, ocv-103, ocv103, ocv 103, ocv-104, ocv104, ocv 104
Latest Update: 2021-01-12
Latest Update Note: Clinical Trial Update

Product Description

OCV-C02 is a peptide vaccine consisting of two peptide epitopes derived from ring finger protein 43 (RNF43) and translocase of outer mitochondrial membrane 34 (TOMM34). a peptide vaccine consisting of two peptide epitopes for refractory metastatic colorectal cancer (Sourced from: https://pubmed.ncbi.nlm.nih.gov/28266765/)

Mechanisms of Action: Vaccine

Novel Mechanism: No

Modality: Vaccine

Route of Administration: Subcutaneous

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: None

Approved Indications: None

Known Adverse Events: None

Company: Otsuka
Company Location: NEW YORK NY 10271
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for OCV-C02

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Phase 1: Colorectal Cancer

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success
JapicCTI-132075

P1

Completed

Colorectal Cancer

2015-01-01

JapicCTI-132075

P1

Unknown

Colorectal Cancer

2015-01-01

Recent News Events

Date

Type

Title

Did PRYZM just deliver the data you were looking for?
Did you try our Excel download too?

Now that you’ve used PRYZM, we hope you’re able to see for yourself that it was designed and developed by people who actually use this data for a living. By applying next-generation technology for aggregating and curating this info across multiple key sources PRYZM delivering the latest information at your fingertips just the way you need it and with industry leading speed and cost effectiveness.

Our subscribers enjoy unlimited searches and receive this data on their own secure instance so they can overlay any additional internal/proprietary data on top of the search results and blend that data with real-time industry intel from PRYZM. Discover how you can continue to uncover the competitive landscape and drive strategy.

Suggestions